FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
<p style="text-align:justify;"> <b>Background:</b> Venous thromboembolism (VTE) occurs when blood clots in the leg, pelvic or other deep vein (deep vein thrombosis) with or without transport of the thrombus into the pulmonary arterial circulation (pulmonary embolus). VTE...
Prif Awduron: | Griffiths, G, Burns, S, Noble, S, Macbeth, F, Cohen, D, Maughan, T |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
BioMed Central
2009
|
Eitemau Tebyg
-
Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer
gan: Macbeth, F, et al.
Cyhoeddwyd: (2009) -
FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in<sup>® </sup><b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer
gan: Macbeth Fergus R, et al.
Cyhoeddwyd: (2009-10-01) -
Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
gan: Dong Qian, et al.
Cyhoeddwyd: (2015-01-01) -
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
gan: Crosby, T, et al.
Cyhoeddwyd: (2017) -
Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial
gan: Sadhna Kannan, et al.
Cyhoeddwyd: (2021-03-01)